Current Affairs

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from...

This kind of news seems to come up with some regular frequency - "To screen or not to screen, that is the question". This Danish study recently reported in the Annals of Internal Medicine found that screening was not associated with a lower...

Last month a joint consensus statement developed by ASCO, the Association for Molecular Pathology (AMP), and the College of American Pathologists (CAP) on standardizing the interpretation and reporting of sequence variants in cancer was...

Fifth Annual Digital Pathology Transforming Medicine in a Digital Age February 20-22, 2017   |   Moscone North Convention Center   |   San Francisco, CA Part of the 24th Annual Molecular Medicine...

As we get ready to flip the calendars over to 2017, a year that seems almost made up from the time I was about 10 in 1980 thinking wasn’t even a real number. By now we were supposed to be flying around in our transport pods with flux...